Thursday, 26 March 2026
  
Login

Australia's most trusted
source of pharma news

Thursday, 26 March 2026
News

Company unveils role 'streamlining'

 Posted 26 March 2026 PM

Takeda has unveiled the next steps in restructuring its business with the company announcing corporate functions will be "streamlined" and processes simplified using technology.

The transformation, which Takeda said aligns with its previously announced organisational structure, is expected to deliver savings of AU$1.81 billion (JPY 200 billion) annually by 2028.

To see the whole article, please login

Popular

PBS giant hangs on tight
Most expensive drug out of stock
Where Drs say pharma falls short
Companies chase listing changes
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home